NEW YORK (GenomeWeb) – Agena Bioscience and Molecular Health said today that they have entered into a strategic partnership under which Molecular Health will use its MH Guide analysis platform to interpret raw data generated by Agena's MassArray system.
The relationship is part of Agena's MassArray Insights reporting network, under which the firm seeks to collaborate with various molecular analysis platform providers.
Specific terms of the agreement were not disclosed, but the firms said that they plan to "cooperate and collaborate with their respective customer bases."
According to Agena CEO Pete Dansky, Moleuclar Helath's data interpretation capabilities answer a currently unmet need for customers using the MassArray platform in the context of laboratory developed tests.
"Many of our customers with [LDTs] have been interested in additional resources for result interpretation. We believe that Molecular Health's data interpretation applications … can greatly streamline the data analysis and interpretation workflow for these customers," Dansky said in a statement.